Amisulpride and Ventricular fibrillation - a phase IV clinical study of FDA data

Summary:

Ventricular fibrillation is reported as a side effect among people who take Amisulpride (amisulpride), especially for people who are female, 60+ old, also take Lithium Carbonate, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Ventricular fibrillation when taking Amisulpride. It is created by eHealthMe based on reports of 6,364 people who have side effects when taking Amisulpride from the FDA, and is updated regularly.

What is Amisulpride?

Amisulpride has active ingredients of amisulpride. eHealthMe is studying from 6,389 Amisulpride users. Check the latest studies of Amisulpride.

What is Ventricular fibrillation?

Ventricular fibrillation (abnormally irregular heart rhythm) is found to be associated with 1,095 drugs and 1,245 conditions by eHealthMe. Check the latest studies of Ventricular fibrillation.

On Jul, 31, 2026

6,364 people reported to have side effects when taking Amisulpride.
Among them, 18 people (0.28%) have Ventricular fibrillation.

Could Amisulpride cause Ventricular fibrillation?

Among these 18 people:

What is the gender of people who have Ventricular fibrillation when taking Amisulpride? *

female: 61.11 %
male: 38.89 %

What is the age of people who have Ventricular fibrillation when taking Amisulpride? *

What are other drugs people take besides Amisulpride? *

What are other side effects people have besides Ventricular fibrillation? *

Arrhythmias (irregular heartbeat): 12 people, 66.67%
Loss Of Consciousness: 10 people, 55.56%
Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 10 people, 55.56%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 9 people, 50.00%
Muscle Rigidity (muscle stiffness): 9 people, 50.00%
Mydriasis (a dilation of the pupil): 9 people, 50.00%
Fever: 9 people, 50.00%
Torsade De Pointes (a abnormal heart rate with abnormal beating pattern): 7 people, 38.89%
Hypotonia (low muscle tone): 5 people, 27.78%
Electrocardiogram Qt Prolonged: 5 people, 27.78%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 7 people, 38.89%
Depression: 6 people, 33.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 27.78%
Cholinergic Syndrome (symptoms of increased cholinergic stimulation): 4 people, 22.22%
Psychotic Disorder: 3 people, 16.67%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 2 people, 11.11%
Cardiac Disorder: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Amisulpride and have Ventricular fibrillation?

- Check whether Ventricular fibrillation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amisulpride:

Amisulpride (6,389 reports)

Browse all side effects of Amisulpride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular fibrillation:

Ventricular fibrillation (1,095 drugs)

Browse all the conditions that are associated with Ventricular fibrillation:

Ventricular fibrillation (1,245 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amisulpride (the active ingredients of Amisulpride) and Amisulpride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.